Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

McKesson Corporation : McKesson wins new two-year Veterans Affairs contract

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/12/2012 | 01:02am CET

Pharmaceutical wholesaler McKesson Corp on Wednesday said it was selected by the U.S. Department of Veterans Affairs to continue as the VA's prime pharmaceutical supplier for at least two more years.

News of the contract, which includes options for up to three two-year extensions, sent shares of McKesson up more than 4 percent in after hours trading.

The new agreement, valued by the VA at over $31.6 billion, calls for McKesson to supply all of the VA's more than 700 medical centers and outpatient clinics, as well as its seven consolidated mail outpatient pharmacies.

"Over the past eight years, McKesson has partnered with the VA to serve the healthcare needs of America's veterans," Paul Julian, the company's executive vice president and group president, said in a statement.

The VA, which estimated savings of about $3.26 billion through the life of the contract, said the new agreement goes into effect on May 10.

Shares of McKesson, which closed at $87.90 on the New York Stock Exchange, were trading at $91.89 after hours.

(Reporting By Deena Beasley, editing by M.D. Golan)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
01/21 City sues three pill distributors, local doctor
01/20 MCKESSON : Specialty Health and The US Oncology Network Invited to Participate i..
01/20 MCKESSON : Finalizes Settlement with U.S. Department of Justice and U.S. Drug En..
01/20MCKESSON CORPORATION : quaterly earnings release
01/19 MCKESSON : Fiscal 2017 Third Quarter Conference Call Scheduled for January 25, 2..
01/19 MCKESSON : Completes Acquisition of Rexall Health and Appoints Domenic Pilla as ..
01/19 MCKESSON : and Change Healthcare Announce Termination of Hart-Scott-Rodino Act W..
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders
01/18 FEDS : McKesson agrees to pay $150M in pill shipment case
More news
Sector news : Drug Retailers - NEC
01/20 FTC NOT SOLD ON WALGREENS' PLAN TO W : Bloomberg
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/18DJMCKESSON : to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders --..
01/11DJWalgreens to Offer FedEx Dropoff and Pickup at Walgreens Locations Nationwide
More sector news : Drug Retailers - NEC
News from SeekingAlpha
01/18 Premarket analyst action - healthcare
01/17 McKesson settles probe over suspicious drug orders for $150M
01/16 9 Dividend Companies With Lower Share Prices
01/10 VALUATION DASHBOARD : Healthcare - Update
01/10 McKesson Corporation (MCK) presents at 35th Annual J.P. Morgan Healthcare Con..
Advertisement
Financials ($)
Sales 2017 199 866 M
EBIT 2017 4 199 M
Net income 2017 2 621 M
Debt 2017 3 835 M
Yield 2017 0,75%
P/E ratio 2017 14,09
P/E ratio 2018 14,02
EV / Sales 2017 0,19x
EV / Sales 2018 0,18x
Capitalization 33 759 M
More Financials
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 159 $
Spread / Average Target 6,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
James A. Beer Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
Wayne A. Budd Independent Director
M. Christine Jacobs Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION6.32%33 976
WALGREENS BOOTS ALLIAN..-1.46%88 209
CVS HEALTH CORP2.97%86 979
EXPRESS SCRIPTS HOLDIN..2.65%44 243
CARDINAL HEALTH INC3.82%24 014
AMERISOURCEBERGEN CORP..8.56%18 433
More Results